Beta-blockers effects according to sex: does selectivity and dose equally matter?

Back

ESC Professional Premium Access

Beta-blockers effects according to sex: does selectivity and dose equally matter?

Session: Pharmacotherapy in heart failure

Topic: Pharmacotherapy

Speaker: Doctor E. Salvioni (Milan, IT)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Elisabetta Salvioni

Monzino Cardiology Centre, Milan (Italy)

0 follower

7 more presentations in this session

Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure

Speaker: Doctor Y. Nishihara (Kobe, JP)

Real world data on adopting guideline directed medical therapy post 2021 ESC HF guidelines and effect on renal function.

Speaker: Mr M. Ferrari (Brescia, IT)

Use of guideline-recommended heart failure drugs in high-, middle- and low-income countries: a systematic review and meta-analysis

Speaker: Associate Professor S. Peters (Utrecht, NL)

Candidacy and predicted efficacy of vericiguat in contemporary heart failure outpatient clinics

Speaker: Doctor B. Soh (Waterford, IE)

Quadruple therapy for heart failure before and after electronic cardiac device implantation - are we hitting our targets?

Speaker: Doctor F. Rode (Zagreb, HR)

Access the full session

Pharmacotherapy in heart failure

Speakers: Doctor E. Salvioni, Doctor Y. Nishihara, Mr M. Ferrari, Associate Professor S. Peters, Doctor B. Soh...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Beta-blockers effects according to sex: does selectivity and dose equally matter?

About the speaker

Doctor Elisabetta Salvioni

7 more presentations in this session

Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure

Real world data on adopting guideline directed medical therapy post 2021 ESC HF guidelines and effect on renal function.

Use of guideline-recommended heart failure drugs in high-, middle- and low-income countries: a systematic review and meta-analysis

Candidacy and predicted efficacy of vericiguat in contemporary heart failure outpatient clinics

Quadruple therapy for heart failure before and after electronic cardiac device implantation - are we hitting our targets?

Access the full session

Pharmacotherapy in heart failure

About the event

ESC Congress 2023

ESC 365 is supported by